Entity DossierOrganization

MERCK & CO INC

NJ · US

pharmaceuticalspharma

Tracked direct giving

Tracked donations to candidate

LDA reported lobbying spend

$16,020,000

Connections

Lobbying Activity Detail

Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.

Top Lobbying Issues

MMMMedicare/Medicaid

$31.1M

HCRHealth Issues

$30.4M

TAXTaxation/Internal Revenue Code

$29.0M

ANIAnimals

$19.8M

TRDTrade

$1.8M

CPTCopyright/Patent/Trademark

$560K

BUDBudget/Appropriations

$440K

PHAPharmacy

$200K

HOMHousing

$50K

Lobbying Firms Retained

MERCK & CO INC$26.9M

W STRATEGIES, LLC$700K

AVENUE SOLUTIONS$700K

WILLIAMS AND JENSEN, PLLC$700K

TIBER CREEK GROUP$650K

CROSSROADS STRATEGIES, LLC$560K

TODD STRATEGY GROUP$510K

THE NICKLES GROUP, LLC$340K

Harbinger Strategies$200K

BROWNSTEIN HYATT FARBER SCHRECK, LLP$200K

Bills Referenced in Lobbying Filings

march-inPBM

Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.

Connection Graph

0 nodes · 0 edgesHover for labels · Double-click to expand

Loading graph...

Person

Organization

PAC

Gov Body

Legislature

Think Tank

Industry

Outcome

Click a node to see details

Double-click to expand its connections

Relationships

Type	Connected To	Details	Source
Employed by	W STRATEGIES, LLC	Hired W STRATEGIES, LLC to lobby on Pharmaceuticals	Source
Lobbied for	CLARITY Act, Digital Asset Market Clarity Act	LDA filing: lobbied on CLARITY Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $2,190,000	Source
Lobbied for	MARCH-IN Rights Proposal (NIH Framework)	LDA filing: lobbied on NIH March-In Rights, period 1st Quarter (Jan 1 - Mar 31), reported amount $40,000	Source
Employed by	CROSSROADS STRATEGIES, LLC	Hired CROSSROADS STRATEGIES, LLC to lobby on NIH March-In Rights	Source
Employed by	TIBER CREEK GROUP	Hired TIBER CREEK GROUP to lobby on Pharmaceuticals	Source
Lobbied for	Pharmacy Benefit Manager Reform Act	LDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $2,930,000	Source
Lobbied for	Action to Delay Effective Date Consistent With Congressionally Enacted Moratorium	Lobbied on pbm — matched LDA filing topic to Federal Register rule.	Source
Contracted with	Department of Health and Human Services	Merck received award from Department of Health and Human Services	Source
Contracted with	Department of Defense	Merck received award from Department of Defense	Source
Lobbied for	Rights to Federally Funded Inventions and Licensing of Government Owned Inventions	Lobbied on march-in — matched LDA filing topic to Federal Register rule.	Source
Employed by	THE NICKLES GROUP, LLC	Hired THE NICKLES GROUP, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2025)	Source
Employed by	AVENUE SOLUTIONS	Hired AVENUE SOLUTIONS to lobby (1st Quarter (Jan 1 - Mar 31) 2023)	Source
Employed by	Harbinger Strategies	Hired HARBINGER STRATEGIES, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2025)	Source
Employed by	TODD STRATEGY GROUP	Hired TODD STRATEGY GROUP to lobby (1st Quarter (Jan 1 - Mar 31) 2023)	Source
Employed by	WILLIAMS AND JENSEN, PLLC	Hired WILLIAMS AND JENSEN, PLLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023)	Source
Employed by	BROWNSTEIN HYATT FARBER SCHRECK, LLP	Hired BROWNSTEIN HYATT FARBER SCHRECK, LLP to lobby (1st Quarter (Jan 1 - Mar 31) 2023)	Source
Affiliated with	Alfred Lumsdaine	MSD (Merck Sharp & Dohme) is the international name for Merck & Co.	Source
Affiliated with	Tony Ramsden	MSD (Merck Sharp & Dohme) is the international name for Merck & Co.	Source
Affiliated with	Margaret Amsden	MSD (Merck Sharp & Dohme) is the international name for Merck & Co.	Source